Report Cover

Global and China Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2026


Nuclear Medicine & Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Nuclear Medicine & Radiopharmaceuticals market is segmented into
    Diagnostic Radioisotopes
    Therapeutic Radioisotopes

Segment by Application, the Nuclear Medicine & Radiopharmaceuticals market is segmented into
    Oncology
    Cardiology
    Other

Regional and Country-level Analysis
The Nuclear Medicine & Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine & Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nuclear Medicine & Radiopharmaceuticals Market Share Analysis
Nuclear Medicine & Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine & Radiopharmaceuticals business, the date to enter into the Nuclear Medicine & Radiopharmaceuticals market, Nuclear Medicine & Radiopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
    Bracco Imaging
    Bayer
    Mallinckrodt
    Nordion
    Triad Isotopes
    Lantheus
    IBA Group
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Advanced Accelerator Applications
    SIEMENS
    Dongcheng
    Navidea
1 Study Coverage
    1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction
    1.2 Market Segments
    1.3 Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type
        1.4.2 Diagnostic Radioisotopes
        1.4.3 Therapeutic Radioisotopes
    1.5 Market by Application
        1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application
        1.5.2 Oncology
        1.5.3 Cardiology
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size, Estimates and Forecasts
        2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2015-2026
        2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026
    2.2 Global Nuclear Medicine & Radiopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Nuclear Medicine & Radiopharmaceuticals Historical Market Size by Region (2015-2020)
        2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2021-2026)
        2.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2021-2026)

3 Global Nuclear Medicine & Radiopharmaceuticals Competitor Landscape by Players
    3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers
        3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2015-2020)
        3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue
        3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
        3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019
        3.2.5 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturers
    3.4 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Types
        3.4.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
        3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (2015-2020)
        4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2015-2020)
        4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2015-2020)
        4.1.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
        4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2021-2026)
        4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
        4.2.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application (2015-2020)
        5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2015-2020)
        5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2015-2020)
        5.1.3 Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020)
    5.2 Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
        5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2021-2026)
        5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
        5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
    6.1 China Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
        6.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales YoY Growth 2015-2026
        6.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue YoY Growth 2015-2026
        6.1.3 China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2015-2026
    6.2 China Nuclear Medicine & Radiopharmaceuticals Market Size by Players (International and Local Players)
        6.2.1 China Top Nuclear Medicine & Radiopharmaceuticals Players by Sales (2015-2020)
        6.2.2 China Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue (2015-2020)
    6.3 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Type (2015-2020)
        6.3.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020)
        6.3.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
        6.3.3 China Nuclear Medicine & Radiopharmaceuticals Price by Type (2015-2020)
    6.4 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2021-2026)
        6.4.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
        6.4.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2021-2026)
    6.5 China Nuclear Medicine & Radiopharmaceuticals Historic Market Review by Application (2015-2020)
        6.5.1 China Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020)
        6.5.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
        6.5.3 China Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020)
    6.6 China Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 China Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2021-2026)
        6.6.2 China Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
        6.6.3 China Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
    7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
        7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020)
        7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
    8.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
        8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
        8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
        9.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020)
        9.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
    10.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
        10.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country
        10.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
        11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
        11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Bracco Imaging
        12.1.1 Bracco Imaging Corporation Information
        12.1.2 Bracco Imaging Description and Business Overview
        12.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.1.5 Bracco Imaging Recent Development
    12.2 Bayer
        12.2.1 Bayer Corporation Information
        12.2.2 Bayer Description and Business Overview
        12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.2.5 Bayer Recent Development
    12.3 Mallinckrodt
        12.3.1 Mallinckrodt Corporation Information
        12.3.2 Mallinckrodt Description and Business Overview
        12.3.3 Mallinckrodt Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.3.5 Mallinckrodt Recent Development
    12.4 Nordion
        12.4.1 Nordion Corporation Information
        12.4.2 Nordion Description and Business Overview
        12.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.4.5 Nordion Recent Development
    12.5 Triad Isotopes
        12.5.1 Triad Isotopes Corporation Information
        12.5.2 Triad Isotopes Description and Business Overview
        12.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.5.5 Triad Isotopes Recent Development
    12.6 Lantheus
        12.6.1 Lantheus Corporation Information
        12.6.2 Lantheus Description and Business Overview
        12.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.6.5 Lantheus Recent Development
    12.7 IBA Group
        12.7.1 IBA Group Corporation Information
        12.7.2 IBA Group Description and Business Overview
        12.7.3 IBA Group Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.7.5 IBA Group Recent Development
    12.8 GE Healthcare
        12.8.1 GE Healthcare Corporation Information
        12.8.2 GE Healthcare Description and Business Overview
        12.8.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.8.5 GE Healthcare Recent Development
    12.9 China Isotope & Radiation
        12.9.1 China Isotope & Radiation Corporation Information
        12.9.2 China Isotope & Radiation Description and Business Overview
        12.9.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.9.5 China Isotope & Radiation Recent Development
    12.10 Jubilant Pharma
        12.10.1 Jubilant Pharma Corporation Information
        12.10.2 Jubilant Pharma Description and Business Overview
        12.10.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.10.5 Jubilant Pharma Recent Development
    12.11 Bracco Imaging
        12.11.1 Bracco Imaging Corporation Information
        12.11.2 Bracco Imaging Description and Business Overview
        12.11.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
        12.11.5 Bracco Imaging Recent Development
    12.12 Advanced Accelerator Applications
        12.12.1 Advanced Accelerator Applications Corporation Information
        12.12.2 Advanced Accelerator Applications Description and Business Overview
        12.12.3 Advanced Accelerator Applications Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 Advanced Accelerator Applications Products Offered
        12.12.5 Advanced Accelerator Applications Recent Development
    12.13 SIEMENS
        12.13.1 SIEMENS Corporation Information
        12.13.2 SIEMENS Description and Business Overview
        12.13.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
        12.13.4 SIEMENS Products Offered
        12.13.5 SIEMENS Recent Development
    12.14 Dongcheng
        12.14.1 Dongcheng Corporation Information
        12.14.2 Dongcheng Description and Business Overview
        12.14.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
        12.14.4 Dongcheng Products Offered
        12.14.5 Dongcheng Recent Development
    12.15 Navidea
        12.15.1 Navidea Corporation Information
        12.15.2 Navidea Description and Business Overview
        12.15.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
        12.15.4 Navidea Products Offered
        12.15.5 Navidea Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Nuclear Medicine & Radiopharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Nuclear Medicine & Radiopharmaceuticals Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Nuclear Medicine & Radiopharmaceuticals Market Segments Table 2. Ranking of Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Diagnostic Radioisotopes Table 5. Major Manufacturers of Therapeutic Radioisotopes Table 6. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions 2015-2020 (K Units) Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions (2015-2020) Table 10. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Units) Table 12. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units) Table 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2015-2020) Table 14. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2019) Table 16. Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2015-2020) (USD/Unit) Table 19. Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type Table 21. Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2015-2020) (K Units) Table 24. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020) Table 25. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million) Table 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020) Table 27. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2026) Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2015-2020) (K Units) Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2015-2020) Table 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2026) Table 32. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026) Table 33. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2015-2020) (US$ Million) Table 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026) Table 35. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Companies (2015-2020) Table 36. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Company (2015-2020) Table 37. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020) Table 38. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2015-2020) Table 39. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020) Table 40. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. China Nuclear Medicine & Radiopharmaceuticals Price (K Units) by Type (2015-2020) Table 42. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2021-2026) Table 43. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2021-2026) Table 44. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2021-2026) Table 46. China Nuclear Medicine & Radiopharmaceuticals Price (K Units) by Type (2021-2026) Table 47. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2015-2020) Table 48. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2015-2020) Table 49. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2021-2026) Table 51. China Nuclear Medicine & Radiopharmaceuticals Sales Share by Application (2021-2026) Table 52. China Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2021-2026) Table 54. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units) Table 55. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) Table 56. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) Table 57. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) Table 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units) Table 59. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) Table 60. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020) (K Units) Table 63. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020) Table 66. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units) Table 67. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Units) Table 71. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) Table 74. Bracco Imaging Corporation Information Table 75. Bracco Imaging Description and Business Overview Table 76. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product Table 78. Bracco Imaging Recent Development Table 79. Bayer Corporation Information Table 80. Bayer Description and Business Overview Table 81. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. Bayer Product Table 83. Bayer Recent Development Table 84. Mallinckrodt Corporation Information Table 85. Mallinckrodt Description and Business Overview Table 86. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Mallinckrodt Product Table 88. Mallinckrodt Recent Development Table 89. Nordion Corporation Information Table 90. Nordion Description and Business Overview Table 91. Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Nordion Product Table 93. Nordion Recent Development Table 94. Triad Isotopes Corporation Information Table 95. Triad Isotopes Description and Business Overview Table 96. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Triad Isotopes Product Table 98. Triad Isotopes Recent Development Table 99. Lantheus Corporation Information Table 100. Lantheus Description and Business Overview Table 101. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. Lantheus Product Table 103. Lantheus Recent Development Table 104. IBA Group Corporation Information Table 105. IBA Group Description and Business Overview Table 106. IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. IBA Group Product Table 108. IBA Group Recent Development Table 109. GE Healthcare Corporation Information Table 110. GE Healthcare Description and Business Overview Table 111. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. GE Healthcare Product Table 113. GE Healthcare Recent Development Table 114. China Isotope & Radiation Corporation Information Table 115. China Isotope & Radiation Description and Business Overview Table 116. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. China Isotope & Radiation Product Table 118. China Isotope & Radiation Recent Development Table 119. Jubilant Pharma Corporation Information Table 120. Jubilant Pharma Description and Business Overview Table 121. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 122. Jubilant Pharma Product Table 123. Jubilant Pharma Recent Development Table 124. Eli Lilly Corporation Information Table 125. Eli Lilly Description and Business Overview Table 126. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 127. Eli Lilly Product Table 128. Eli Lilly Recent Development Table 129. Advanced Accelerator Applications Corporation Information Table 130. Advanced Accelerator Applications Description and Business Overview Table 131. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 132. Advanced Accelerator Applications Product Table 133. Advanced Accelerator Applications Recent Development Table 134. SIEMENS Corporation Information Table 135. SIEMENS Description and Business Overview Table 136. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 137. SIEMENS Product Table 138. SIEMENS Recent Development Table 139. Dongcheng Corporation Information Table 140. Dongcheng Description and Business Overview Table 141. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 142. Dongcheng Product Table 143. Dongcheng Recent Development Table 144. Navidea Corporation Information Table 145. Navidea Description and Business Overview Table 146. Navidea Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 147. Navidea Product Table 148. Navidea Recent Development Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 150. Key Challenges Table 151. Market Risks Table 152. Main Points Interviewed from Key Nuclear Medicine & Radiopharmaceuticals Players Table 153. Nuclear Medicine & Radiopharmaceuticals Customers List Table 154. Nuclear Medicine & Radiopharmaceuticals Distributors List Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026 Figure 3. Diagnostic Radioisotopes Product Picture Figure 4. Therapeutic Radioisotopes Product Picture Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026 Figure 6. Oncology Figure 7. Cardiology Figure 8. Other Figure 9. Nuclear Medicine & Radiopharmaceuticals Report Years Considered Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2015-2026 (US$ Million) Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026 (K Units) Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020) Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019 Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020) Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019 Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019 Figure 19. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020) Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2019 Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020) Figure 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type in 2019 Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Range (2015-2020) Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020) Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2019 Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020) Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2019 Figure 29. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2026 (K Units) Figure 30. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. China Nuclear Medicine & Radiopharmaceuticals Market Share in Global Market 2015-2026 Figure 32. China 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine & Radiopharmaceuticals in 2019 Figure 33. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020) Figure 34. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019 Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Share by Application (2015-2020) Figure 36. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units) Figure 38. North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 Figure 40. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 Figure 41. U.S. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 Figure 48. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 Figure 49. Germany Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 52. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019 Figure 62. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019 Figure 63. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 64. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 70. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 Figure 88. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 Figure 89. Mexico Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 Figure 99. Turkey Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Nuclear Medicine & Radiopharmaceuticals Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Stadium Seats Market Research Report 2020

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...

Global Pneumatic Hammers Market Research Report 2020

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...

Global Casual and Sports Insoles Market Research Report 2020

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...

Global Dimethyl Benzyl Carbinyl Acetate Market Research Report 2020

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...

Global Aerospace Polymer Composites Market Research Report 2020

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...

Publisher: QY Research
Chat with us